The Shortcomings of COVID-19 Testing in Ecuador: Time to Incentivize Research and Innovation

被引：1

作者：

Chalen, Izan ^{[1
,2
,3
]}

Mercedes Cobo, Maria ^{[1
,4
]}

Gutierrez, Bernardo ^{[1
,5
]}

Carrazco-Montalvo, Andres ^{[1
,6
]}

Ponce, Patricio ^{[6
]}

Cisneros-Heredia, Diego F. ^{[1
,3
]}

机构：

[1] Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales COCIBA, Quito 170901, Ecuador

[2] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA

[3] Univ San Francisco Quito USFQ, Inst Ibiotrop, Quito 170901, Ecuador

[4] Univ Oxford, Dept Paediat, Oxford OX3 9DU, England

[5] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England

[6] Inst Nacl Invest Salud Publ, Quito 170136, Ecuador

来源：

LIFE-BASEL | 2022年 / 12卷 / 03期

关键词：

coronavirus; research and development; diagnosis; biotechnology industry;

D O I：

10.3390/life12030325

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The COVID-19 pandemic hit Ecuador severely. The country caught the attention of international media due to its high death toll and overwhelmed healthcare system. The clinical diagnostics system was rapidly overloaded, and the import of PCR tests was delayed. The case of Ecuador illustrates how middle-income countries rely heavily on the importation of biotechnological products for their healthcare systems. The Ecuadorian experience during the COVID-19 pandemic serves as a call for the formation of policies for the development of the biotechnological industry.

引用

页数：4

共 13 条

[1] BEYOND OMICRON: WHAT'S NEXT FOR SARS-COV-2 EVOLUTION
Callaway, Ewen
[J]. NATURE, 2021, 600 (7888) : 204 - 207
[2] First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
Carrazco-Montalvo, A.
Armendariz-Castillo, I.
Tello, C. L.
Morales, D.
Armas-Gonzalez, R.
Guizado-Herrera, D.
Leon-Sosa, A.
Ramos-Sarmiento, D.
Fuertes, B.
Cardenas, P.
Marquez, S.
Prado-Vivar, B.
Guadalupe, J. J.
Gutierrez, B.
Grunauer, M.
Trueba, G.
Rojas-Silva, P.
Patino, V. Barragan L.
[J]. NEW MICROBES AND NEW INFECTIONS, 2022, 45
[3] Unifying the epidemiological and evolutionary dynamics of pathogens
Grenfell, BT
Pybus, OG
Gog, JR
Wood, JLN
Daly, JM
Mumford, JA
Holmes, EC
[J]. SCIENCE, 2004, 303 (5656) : 327 - 332
[4] Perspective from Ecuador, the Second Country with More Confirmed Cases of Coronavirus Disease 2019 in South America: A Review
Hallo, Alejandro
Rojas, Alejandra
Hallo, Carlos
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
[5] Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset
Karlinsky, Ariel
Kobak, Dmitry
[J]. ELIFE, 2021, 10
[6] Predicting the mutational drivers of future SARS-CoV-2 variants of concern
Maher, M. Cyrus
Bartha, Istvan
Weaver, Steven
di Iulio, Julia
Ferri, Elena
Soriaga, Leah
Lempp, Florian A.
Hie, Brian L.
Bryson, Bryan
Berger, Bonnie
Robertson, David L.
Snell, Gyorgy
Corti, Davide
Virgin, Herbert W.
Pond, Sergei L. Kosakovsky
Telenti, Amalio
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (633)
[7] A case of SARS-CoV-2 reinfection in Ecuador
Prado-Vivar, Belen
Becerra-Wong, Monica
Guadalupe, Juan Jose
Marquez, Sully
Gutierrez, Bernardo
Rojas-Silva, Patricio
Grunauer, Michelle
Trueba, Gabriel
Barragan, Veronica
Cardenas, Paul
[J]. LANCET INFECTIOUS DISEASES, 2020, 21 (06) : E142 - E142
[8] The developing world needs more than numbers
Rochmyaningsih, Dyna
[J]. NATURE, 2017, 542 (7639) : 7 - 7
[9] Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
Saad-Roy, Chadi M.
Morris, Sinead E.
Metcalf, C. Jessica E.
Mina, Michael J.
Baker, Rachel E.
Farrar, Jeremy
Holmes, Edward C.
Pybus, Oliver G.
Graham, Andrea L.
Levin, Simon A.
Grenfell, Bryan T.
Wagner, Caroline E.
[J]. SCIENCE, 2021, 372 (6540) : 363 - 370
[10] COVID-19 spurs wave of innovative diagnostics
Sheridan, Cormac
[J]. NATURE BIOTECHNOLOGY, 2020, 38 (07) : 769 - 772

← 1 2 →